|
Market Cap (4-Jul) $617,755,968 (1,200th) |
Close (30-Jun) $0.130 |
Volume (30-Jun) 13,196,801 |
Shortsold (19-Jun) 70,661,833 (3.60%) (67th) |
|
52w High $0.54 |
52w Low $0.283 |
P/E - |
EPS -0.02 |
BOT released this announcement to the ASX on 13 October 2022, 9:47. The announcement is marked as price sensitive, and is 17 page(s) in length and 5.36MB in size.
You can view all announcements from BOT and see how they appear on a price chart on the announcements page.
At the date of this announcement, BOT was 0.158% short sold according to ASIC data. It was ranked the 445th most shorted stock on the ASX. It is now ranked as the 67th most shorted stock on the ASX with 3.604% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from BOT | |
|---|---|
| Section 708A(5)(e) Notice | 27 June 2023, 19:11 |
| Application for quotation of securities - BOT | 27 June 2023, 19:07 |
| Section 708A(5)(e) Notice | 15 June 2023, 14:07 |
| Positive BTX 1702 Phase 1b/2 Clinical Study for Rosacea | 13 October 2022, 9:47 |
| Trading Halt | 12 October 2022, 9:50 |
| BOT Submits FDA New Drug Application for Sofpironium Bromide | 26 September 2022, 8:19 |
| Appendix 4G | 16 September 2022, 17:37 |
You must be logged in to post a reply.
Botanix Pharmaceuticals 